Clinical Trial Details
EORTC-30974
Back to Clinical Trials Database
A ranomized phase III study of sequential high-dose Cisplatinum/Etoposide/Ifosfamide plus stem cell support versus BEP in patients with poor prognosis Germ Cell Cancer
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 28-Apr-1999 Date Step1 close: 18-Jun-2007 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 222 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00003941 |
NCT number | NCT00003941 |